NEW YORK (TheStreet) -- CHANGE IN RATINGS

Amylin Pharmaceuticals

( AMLN) downgraded at BMO from Market Perform to Underperform. $12 price target. LAR approval could be delayed until late 2011, as the FDA will likely request more clinical data.

Avery Dennison

(AVY) - Get Report

downgraded at BofA/Merrill to Neutral from Buy as valuation and fundamentals are less compelling. $35 price target.

Boeing

(BA) - Get Report

upgraded at UBS from Sell to Neutral. $68 price target. Estimates also boosted, because of a higher delivery forecast.

Convergys

(CVG)

downgraded at Kaufman from Hold to Sell. Valuation call, as the stock is up 16% since the recent CEO change. $11 price target.

Disney

(DIS) - Get Report

upgraded at BofA/Merrill to Buy from Neutral on expectations that 2011 earnings will beat expectations. Estimates raised through 2012. Price target boosted to $42 from $33.

Dole Food

(DOLE)

rated new Equal-weight at Morgan Stanley. Core fruit business has limited upside potential from current levels.

FedEx

(FDX) - Get Report

upgraded at Morgan Keegan from Market Perform to Outperform. Company has strong earnings leverage as volumes recover.

Coca-Cola

(KO) - Get Report

upgraded at UBS from Neutral to Buy. $62 price target. Valuation call, as the company has been showing strong volume and cash flow growth.

Liberty Starz

( LSTZA) rated new Buy at UBS. $65 price target. Stock is overly discounting future programming costs and sports and attractive 10% free cash flow yield.

Madison Square Garden

(MSG) - Get Report

rated new Neutral at UBS. Coverage of MSG was started with a Neutral rating. $22 price target. Company will spend more to upgrade its arena in 2011. Valuation also appears high.

Royal Caribbean

(RCL) - Get Report

upgraded at Goldman from Sell to Neutral. Estimates also raised, as the new Oasis and Solstice ships are showing a significant relative premium. $27 price target.

Spirit Aerosystems

(SPR) - Get Report

upgraded at UBS from Sell to Neutral. $22 price target. Higher deliveries should drive earnings.

STOCK COMMENTS / EPS CHANGES

Accenture

(ACN) - Get Report

estimates tweaked at Credit Suisse. ACN 2010 and 2011 EPS estimates lowered to $2.65 and $2.99, respectively. Currency drags. Maintain Outperform rating and $55 target.

Altra

(AIMC) - Get Report

target, estimates raised at BofA/Merrill. AIMC price target increased by $2 to $15 on higher earnings estimates. 2010 and 2011 EPS estimates raised to $0.85 and $1.15, respectively. Maintain Buy.

Alon USA Energy

(ALJ)

target, estimate cut at Barclays. ALJ price target trimmed by a dollar to $6 on weak 4Q09 results. 2010 EPS estimate lowered to -$1.85. Underweight rating.

Anadarko Petroleum

(APC) - Get Report

target raised at FBR to $90. Company has very attractive exploration opportunities. Outperform rating.

BJ's Wholesale

(BJ) - Get Report

numbers lowered at Goldman. BJ estimates were cut through 2011. Company is ramping up internal investments. Sell rating and new $31 price target.

Costco

(COST) - Get Report

estimates lowered at Goldman through 2012. Gross margin is facing more difficult comparisons. Neutral rating and $61 price target.

Energizer

(ENR) - Get Report

estimates, target increased at Goldman. ENR estimates were boosted through 2012. New Schick and Edge razors should drive organic sales growth. Neutral rating and new $68 price target.

Finisar

(FNSR) - Get Report

price target boosted at Credit Suisse. FNSR price target raised to $13.50 from $11 after solid 3Q10 results. Neutral rating. 2010 and 2011 EPS estimates set at 52 cents and 90 cents, respectively.

Hershey

( JOYG) estimates, target boosted at UBS. Shares of HSY now seen reaching $42. Estimates also raised, as the new analyst believes that the company is gaining brand momentum. Neutral rating.

Joy Global

( JOYG) estimate tweaked at Barclays. JOYG 2010 EPS estimate inched up to 3.10, 2011 maintained at $3.95. Maintain Overweight rating and $67 price target.

Joy Global

( JOYG) estimates, target upped at Goldman. Shares of JOYG now seen reaching $64. Estimates also boosted, given higher equipment production. Neutral rating.

Kroger

(KR) - Get Report

estimates upped at Morgan Stanley through 2011. Company is being less aggressive with pricing and gross margin should stabilize. Equal-weight rating.

Las Vegas Sands

(LVS) - Get Report

numbers cut at Goldman through 2011. Company seeing lower profits in Las Vegas properties. Neutral rating and new $17 price target.

Mariner Energy

( ME) price target raised at Credit Suisse by a dollar to $18 as it continues to build its onshore asset base. 2010 and 2011 EPS estimates changed to -$0.29 and $0.13, respectively. Maintain Outperform rating.

NYSE Euronext

(NYX)

numbers increased at Goldman. Shares of NYX now seen reaching $32. Estimates also boosted, as management is cutting costs and should be able to generate incremental revenue growth.

PetSmart

(PETM)

price target higher at Credit Suisse. PETM price target surged to $35 from $29. PetSmart is one of our most attractive manes going forward, Credit Suisse said. 2011 and 2012 EPS estimates raised to $1.85 and $2.13, respectively. Maintain Outperform rating.

PetSmart

(PETM)

estimates, target raised at Goldman. Shares of PETM now seen reaching $32. Estimates also upped, to reflect an active share repurchase program. Neutral rating.

Staples

(SPLS)

target lowered at Citigroup. Shares of SPLS now seen reaching $26. Stock could receive a more conservative multiple, following the company's lower earnings guidance. Buy rating.

Torchmark

(TMK)

price target boosted at BofA/Merrill to $57 from $55 as share buybacks resume. 2011 EPS estimate bumped up to $6.75. Reiterate Buy.

Texas Instruments

(TXN) - Get Report

price target higher at Thomas Weisel, to $32 from $30 on solid guidance. Maintain Overweight rating.

URS Corp

(URS)

target, estimate raised at Barclays. URS price target increased a dollar to $53 on strong 2010 guidance. 2010 EPS estimate jumped 10 cents to $3.45. Equal Weight rating.

URS

(URS)

estimates, target increased at UBS. Shares of URS now seen reaching $51. Estimates also raised, to match the company's new guidance. Neutral rating.

This article was written by a staff member of TheStreet.com.